Healthcare - Biotechnology - NASDAQ - US
$ 2.427
-4.45 %
$ 2.93 M
Market Cap
-0.5
P/E
BALANCE SHEET
3.58 M
ASSETS
433 K
LIABILITIES
3.14 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Lipella Pharmaceuticals Inc.
| Current Assets | 3.43 M |
| Cash & Short-Term Investments | 3.29 M |
| Receivables | 32.3 K |
| Other Current Assets | 103 K |
| Non-Current Assets | 148 K |
| Long-Term Investments | 0 |
| PP&E | 148 K |
| Other Non-Current Assets | 0 |
| Current Liabilities | 385 K |
| Accounts Payable | 138 K |
| Short-Term Debt | 89.2 K |
| Other Current Liabilities | 158 K |
| Non-Current Liabilities | 47.4 K |
| Long-Term Debt | 47.4 K |
| Other Non-Current Liabilities | 0 |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| ASSETS | |||||
| Cash & Cash Equivalents | 3.3 | 5.1 | 1.4 | 0.6 | 26 K |
| Short Term Investments | 0 | 0 | 0.3 | 0 | 0 |
| Receivables | 32.3 K | 0.1 | 0 | 69 K | 83.9 K |
| Inventory | 0 | (0.1) | 0 | 0 | 0 |
| Other Current Assets | 0.1 | 0.6 | 93.7 K | 23.7 K | 92.9 K |
| Total Current Assets | 3.4 | 5.8 | 1.8 | 0.7 | 0.1 |
| PP&E | 0.1 | 0.2 | 0.2 | 0.3 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0 | 0 | 0 | 0 | 0 |
| Other Long Term Assets | 0 | (0.2) | (0.2) | (0.3) | 0 |
| Other Assets | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 3.6 | 6.0 | 2.0 | 1.0 | 0.1 |
| LIABILITIES | |||||
| Accounts Payable | 0.1 | 0.4 | 46.9 K | 24.5 K | 49.3 K |
| Short Term Debt | 89.2 K | 0.3 | 64.6 K | 0.1 | 50 K |
| Other Current Liabilities | 0.2 | 0.5 | (0.1) | 27.3 K | 66.3 K |
| Total Current Liabilities | 0.4 | 1.2 | 0.3 | 0.2 | 0.2 |
| Long Term Debt | 47.4 K | 96.3 K | 0.2 | 0.3 | 50 K |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 0 | 0 | 30.3 K | 26 K | 21.6 K |
| Total Liabilities | 0.4 | 1.3 | 0.6 | 0.5 | 0.2 |
| EQUITY | |||||
| Common Stock | 605 | 574 | 967 | 574 | 520 |
| Retained Earnings | (10.3) | (5.7) | (3.1) | (1.2) | (1.2) |
| Other Accumulative Comprehensive Income/Loss | 0 | 0 | (3.1) | (1.2) | (1.2) |
| Total Equity | 3.1 | 4.7 | 1.4 | 0.5 | (0.1) |
| Total Liabilities and Equity | 3.6 | 6.0 | 2.0 | 1.0 | 0.1 |
| SHARES OUTSTANDING | |||||
| Common Shares Outstanding | 6.0 | 5.7 | 5.7 | 5.7 | 5.7 |